74 related articles for article (PubMed ID: 6745084)
1. Receptor theories and quantitative effect versus dose-concentration relationship.
Tallarida RJ
Drug Metab Rev; 1984; 15(1-2):345-63. PubMed ID: 6745084
[TBL] [Abstract][Full Text] [Related]
2. The use of drug-receptor affinity measures in the differentiation of receptors.
Tallarida RJ
Fed Proc; 1982 May; 41(7):2323-7. PubMed ID: 6122613
[TBL] [Abstract][Full Text] [Related]
3. Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions.
Kenakin TP
Mol Pharmacol; 1992 Apr; 41(4):699-707. PubMed ID: 1569922
[TBL] [Abstract][Full Text] [Related]
4. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens.
Minneman KP; Fox AW; Abel PW
Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
Bertalmio AJ; Woods JH
J Pharmacol Exp Ther; 1987 Nov; 243(2):591-7. PubMed ID: 2824753
[TBL] [Abstract][Full Text] [Related]
6. Affinity of normorphine for its pharmacologic receptor in the naive and morphine-tolerant guinea-pig isolated ileum.
Porreca F; Burks TF
J Pharmacol Exp Ther; 1983 Jun; 225(3):688-93. PubMed ID: 6306216
[TBL] [Abstract][Full Text] [Related]
7. Receptor interactions of imidazolines. IX. Cirazoline is an alpha-1 adrenergic agonist and an alpha-2 adrenergic antagonist.
Ruffolo RR; Waddell JE
J Pharmacol Exp Ther; 1982 Jul; 222(1):29-36. PubMed ID: 6123592
[TBL] [Abstract][Full Text] [Related]
8. The Schild regression in the process of receptor classification.
Kenakin TP
Can J Physiol Pharmacol; 1982 Mar; 60(3):249-65. PubMed ID: 7042056
[TBL] [Abstract][Full Text] [Related]
9. Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.
Shannon HE; Cone EJ; Gorodetzky CW
J Pharmacol Exp Ther; 1984 Jun; 229(3):768-74. PubMed ID: 6547177
[TBL] [Abstract][Full Text] [Related]
10. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
11. Antagonist inhibition curves and the measurement of dissociation constants.
Barlow RB; Bond SM; Bream E; Macfarlane L; McQueen DS
Br J Pharmacol; 1997 Jan; 120(1):13-8. PubMed ID: 9117087
[TBL] [Abstract][Full Text] [Related]
12. Limitations of Schild plots in a two-receptor system: alpha adrenoceptors of vascular smooth muscle.
Milnor WR
J Pharmacol Exp Ther; 1986 Jul; 238(1):237-41. PubMed ID: 3014117
[TBL] [Abstract][Full Text] [Related]
13. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
14. Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation.
Regunathan S; Youngson C; Raasch W; Wang H; Reis DJ
J Pharmacol Exp Ther; 1996 Mar; 276(3):1272-82. PubMed ID: 8786560
[TBL] [Abstract][Full Text] [Related]
15. Cooperativity in classical receptor theory.
Scaf AH
Arch Int Pharmacodyn Ther; 1975 May; 215(1):4-12. PubMed ID: 1164085
[TBL] [Abstract][Full Text] [Related]
16. Calcium influx-dependent and -independent alpha 1-adrenoceptor-mediated processes of vasoconstriction in vivo do not operate via different alpha 1-adrenoceptor subtypes.
Korstanje C; Wilffert B; de Jonge A; Thoolen MJ; Timmermans PB; van Zwieten PA
J Cardiovasc Pharmacol; 1984; 6(6):1102-8. PubMed ID: 6084766
[TBL] [Abstract][Full Text] [Related]
17. Insights into the unusual alpha adrenoceptor subtype in dog saphenous vein using phenoxybenzamine.
Low AM; Lu-Chao H; Loke JC; Kwan CY; Daniel EE
J Pharmacol Exp Ther; 1999 Jan; 288(1):148-56. PubMed ID: 9862765
[TBL] [Abstract][Full Text] [Related]
18. The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: application to the analgesic effect of morphine.
Tallarida RJ; Harakal C; Maslow J; Geller EB; Adler MW
J Pharmacol Exp Ther; 1978 Jul; 206(1):38-45. PubMed ID: 660555
[TBL] [Abstract][Full Text] [Related]
19. [Antagonistic characterization of 1-(2,6-dimethylphenoxyl)-2-(3,4-dimethylphenyl ethylamino) propane hydrochloride on alpha 1-adrenoceptor].
Lu ZZ; Zhang YY; Xia L; Han QD
Yao Xue Xue Bao; 2000 Oct; 35(10):739-42. PubMed ID: 11372438
[TBL] [Abstract][Full Text] [Related]
20. Parameters of drug antagonism: re-examination of two modes of functional competitive drug antagonism on intraocular muscles.
Patil PN
J Pharm Pharmacol; 2004 Aug; 56(8):1045-53. PubMed ID: 15285850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
